期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY LetPub Score 6.6
50 ratings
Rate
Reputation 7.5 Influence 5.1 Speed 9.5 | ||||||||||||||||||||
期刊簡稱 | EUR J CLIN PHARMACOL | ||||||||||||||||||||
ISSN | 0031-6970 | ||||||||||||||||||||
E-ISSN | 1432-1041 | ||||||||||||||||||||
h-index | 99 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 4.20%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.springer.com/228 | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/ejcl | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Springer Berlin Heidelberg | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | GERMANY | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1968 | ||||||||||||||||||||
每年文章數 | 153每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 32.62% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0031-6970%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-8 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY] 的評論 | 撰寫評論 |
作者: jiangluer 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-06-05 23:41:32 評論於 Yes, I submitted to the OA, it's faster, and usually takes around 3 months for acceptance and 4 months to publication(0) 讚! | jiangluer |
作者: camellial 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-31 15:32:13 評論於 Is the traditional publishing model free of charge, how long does the review process typically take, and how long until publication?(0) 讚! | camellial |
作者: jiangluer 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-10-31 17:12:41 評論於 Relatively easy to accept, innovative points are fairly easy, and the editor is easy to talk to. After major revisions, the review process is a bit slow, the journal takes a long time to find reviewers, and the APC processing fee is too expensive, over 4000 dollars(0) 讚! | jiangluer |
作者: 是亚飞吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-17 09:49:30 評論於 Does this journal have an impact factor? I confused it with the European Journal of Pharmacology when I checked. Someone told me that it does not have an impact factor, so it does not count as an SCI article, and the article processing fee cannot be reimbursed(0) 讚! | 是亚飞吖 |
作者: 北国半蕾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-19 15:58:54 評論於 Do you need to pay for layout fee?(0) 讚! | 北国半蕾 |
作者: 玉萧如白 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-03 17:48:46 評論於 Do you have any experience of changing the corresponding author after acceptance?(0) 讚! | 玉萧如白 |
作者: 玉萧如白 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-03 09:02:02 評論於 Do you have any experience of changing the corresponding author after acceptance?(0) 讚! | 玉萧如白 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:19:47 評論於 Almost all freely submitted academic papers that meet the publication requirements after review need to be returned to the authors for revisions before publication. This may involve editing the expression and formatting, such as compressing the length of the paper, redesigning tables, improving the quality of illustrations, and restricting the use of irregular abbreviations. However, returning the manuscript to the authors for revisions does not mean that the article has been accepted. The final acceptance of the article depends on whether the author's modifications to the key elements and expression of the article meet the requirements of the reviewers and editors. The materials usually returned to the authors for revisions include the original manuscript, reviewers' comments, and a cover letter from the editor. When authors receive the revised manuscript, they should carefully read the cover letter and reviewers' comments. They should then consider whether they can or are willing to accept the reviewers' or editor's suggestions and make revisions. The likelihood of the article being accepted can be seen from the responses of the chief editor and reviewers to the revised manuscript. Revisions should not be rushed, and authors should carefully read and understand the reviewers' questions. They should respond to each reviewer's comments individually and specifically indicate the modifications made in the revised manuscript (page, lines). In the response to the chief editor, authors should express gratitude for the suggested revisions and explain reasons for areas where modifications were not made(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:21:42 評論於 Submission completed - Formatting review - Initial editor review - Peer review - Review completed - Final editor review - Author revisions(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 14:24:47 評論於 What is the process of a refund?(0) 讚! | 陶宜三岁啦 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 11:38:42 評論於 What is the process for peer review?(0) 讚! | Oswald Edie |
作者: Zsf123 領域: 医学 審稿時間: 2.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-15 09:35:51 評論於 May I ask, it has been over two months since I submitted. The submission interface still shows "Reviewers Assigned." What does this status mean? Do I have to wait for the "under review" stage?(0) 讚! | Zsf123 |
作者: 天山孤萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-22 13:49:45 評論於 Review speed: 6.0 | Submission acceptance rate: 25.0 Experience sharing: The first SCI clinical article in my life was submitted on November 10, 2019. During the process, I encountered opinions from 2 reviewers that could not be determined, so a third arbitration was added. Major revisions were made on February 1, 2020, addressing 17 major issues and providing a 14-page response. Minor revisions were made during the second review, and the article was finally accepted on May 20. It is worth commemorating(0) 讚! | 天山孤萍 |
作者: 潜龙乐易 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-13 11:30:07 評論於 Interested in receiving articles on the pharmacology of traditional Chinese medicine? Chelsey 2020-03-10 09:11:00 Published: Journal Name: European Journal of Clinical Pharmacology Field: Clinical Pharmacology Country: Sweden Submission Date: 2019-12-18 Submission Method (online submission system or postal submission, please provide submission link if online): https://www.springer.com/journal/228 Revised Date: 2020-01-23 Revision Method (major revision, minor revision, rejection): Major revision once Acceptance Date: 2020-02-26 Does it charge page fees: No Sharing Experience or Lessons: Both review and publication efficiency are very high(0) 讚! | 潜龙乐易 |
作者: 傲寒问蕊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-04 18:25:50 評論於 Haha, it's really fate... Brother die(0) 讚! | 傲寒问蕊 |
作者: Nora Bertha 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-24 19:45:16 評論於 Can clinical trial articles be received?(0) 讚! | Nora Bertha |
作者: 羽蒙 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2020-03-17 17:31:07 評論於 Editors of this journal preferred the research with clinical patient data. However, the processing efficiency was high! It took about one month for external review. (2) 讚! | 羽蒙 |
作者: 平原啸天 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-17 16:33:04 評論於 Review speed: 1.0 Experience sharing: The journal prefers research with clinical patient data aspects, but the efficiency is high! External review takes about a month(0) 讚! | 平原啸天 |
作者: 长安歆艺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-10 18:17:06 評論於 Review speed: 1.0 | Submission acceptance rate: 75.0 Experience sharing: Journal Name: European Journal of Clinical Pharmacology Field of expertise: Clinical Pharmacology Journal country: Sweden Submission date: 2019-12-18 Submission method (submission system or mail, if there is a submission system, please provide the submission link): https://www.springer.com/journal/228 Revision date: 2020-01-23 Mode of revision (major revision, minor revision, rejection): major revision once Acceptance date: 2020-02-26 Whether there is a page charge: No Experience sharing or lessons: Both the review and publication efficiency are very high(0) 讚! | 长安歆艺 |
作者: 长安歆艺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-10 14:30:36 評論於 Review speed: 1.0 | Submission success rate: 75.0 Experience sharing: Journal Name: European Journal of Clinical Pharmacology Area of expertise: Clinical Pharmacology Journal Country: Sweden Submission Date: 2019-12-18 Submission method (submission system or mailing, if there is a submission system, please provide the submission link): https://www.springer.com/journal/228 Revision Date: 2020-01-23 Way of revision (major revision, minor revision, rejection): Major revision once Acceptance Date: 2020-02-26 Is there a page fee: No Shared experience or lessons: The review and publication efficiency are very high(0) 讚! | 长安歆艺 |
作者: 长安歆艺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-10 14:21:03 評論於 Review speed: 1.0 | Submission hit rate: 75.0 Experience sharing: Journal name: European Journal of Clinical Pharmacology Specialty: Clinical Pharmacology Journal country: Sweden Submission date: 2019-12-18 Submission method (submission system or mail, please provide submission link if there is a submission system): https://www.springer.com/journal/228 https://www.editorialmanager.com/ejcl Revision date: 2020-01-23 Revision method (major revision, minor revision, rejection): Major revision once Acceptance date: 2020-02-26 Is there a page fee: No Sharing experience or lessons learned: Phase I PK/PD research, tragically did not receive under review when submitted to other journals before, submitted to EJCP and received quick feedback, very efficient review and publication process(0) 讚! | 长安歆艺 |
作者: 长安歆艺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-09 11:16:03 評論於 Review speed: 1.0 | Submission hit rate: 75.0 Experience sharing: Journal name: European Journal of Clinical Pharmacology Field of expertise: Clinical pharmacology Journal country: Sweden Submission date: 2019-12-18 Submission method (submission system or by mail, if there is a submission system, please provide the submission link): https://www.springer.com/journal/228 https://www.editorialmanager.com/ejcl Revision date: 2020-01-23 Revision method (major revision, minor revision, rejection): Major revision once Acceptance date: 2020-02-26 Is there a page fee: No Sharing of experience or lessons learned: I Phase I PK/PD study, previously submitted to other journals without under review, tragic, submitted to EJCP, feedback was very quick, review and publication efficiency very high(0) 讚! | 长安歆艺 |
作者: 辉夜碧秋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-30 11:02:37 評論於 When did you submit that meta? I want to submit mine too(0) 讚! | 辉夜碧秋 |
作者: 韦陀灵萱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-05-25 17:01:57 評論於 My first SCI paper, gratitude for the acceptance back then, in a reputable journal, with an impact factor of 2.98, a meta-study(0) 讚! | 韦陀灵萱 |
作者: 水蓝色 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-04-06 11:28:02 評論於 Hired after two major repairs.Each month 1(0) 讚! | 水蓝色 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us